Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

NCT02297230 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02297230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02297230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Lead sponsor
NYU Langone Health
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2002
Completion date
December 2, 2014
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer